In vitro evaluation of inhibitory effect of nuclear factor-kappab activity by small interfering RNA on pro-tumor characteristics of m2-like macrophages

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 1, 2014, Pages 137-144

  Kono, Yusuke ^a   Kawakami, Shigeru ^b   Higuchi, Yuriko ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Nuclear factor kappaB; Small interfering RNA; Transfection; Tumor associated macrophage

Indexed keywords

ARGINASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MELANOMA; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; ARGINASE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOKINES; INTERLEUKINS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MACROPHAGES, PERITONEAL; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; NITRIC OXIDE; PHENOTYPE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TH1 CELLS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892584449     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00659     Document Type: Article

References (37)

1. Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol. Lett., 123, 97-102 (2009).
2. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev., 25, 315-322 (2006).
3. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 4, 71-78 (2004).
4. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J. Clin. Pathol., 65, 159-163 (2012).
5. Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M, Morii E, Aozasa K. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch., 459, 361-366 (2011).
6. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J. Transl. Med., 9, 216 (2011).
7. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front. Biosci., 13, 453-461 (2008).
8. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Scientific World Journal, 11, 2391-2402 (2011).
9. Mosser DM. The many faces of macrophage activation. J. Leukoc. Biol., 73, 209-212 (2003).
10. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol., 3, 23-35 (2003).
11. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 23, 549-555 (2002).
12. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol., 2012, 1-11 (2012).
13. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: A new and highly effective antiangiogenic therapy approach. Br. J. Cancer, 95, 272-281 (2006).
14. Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, Costa S, Vinckier S, Dresselaer T, Akerud P, De Mol M, Salomäki H, Phillipson M, Wyns S, Larsson E, Buysschaert I, Botling J, Himmelreich U, Van Ginderachter JA, De Palma M, Dewerchin M, Claesson-Welsh L, Carmeliet P. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PIGF. Cancer Cell, 19, 31-44 (2011).
15. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR. "Re-educating" tumorassociated macrophages by targeting NF-κB. J. Exp. Med., 205, 1261-1268 (2008).
16. Shime H, Matsumoto M, Oshiumi H, Tanaka S, Nakane A, Iwakura Y, Tahara H, Inoue N, Seya T. Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc. Natl. Acad. Sci. U.S.A., 109, 2066-2071 (2012).
17. Wang YC, He F, Feng F, Liu XW, Dong GY, Qin HY, Hu XB, Zheng MH, Liang L, Feng L, Liang YM, Han H. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res., 70, 4840-4849 (2010).
18. Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumorassociated macrophages-mediated T cell deletion. J. Immunol., 174, 4880-4891 (2005).
19. Schmieder A, Michel J, Schönhaar K, Goerdt S, Schledzewski K. Differentiation and gene expression profile of tumor-associated macrophages. Semin. Cancer Biol., 22, 289-297 (2012).
20. DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer. Immunol. Rev., 246, 379-400 (2012).
21. Mancino A, Lawrence T. Nuclear factor-κB and tumor-associated macrophages. Clin. Cancer Res., 16, 784-789 (2010).
22. Biswas SK, Lewis CE. NF-κB as a central regulator of macrophage function in tumors. J. Leukoc. Biol., 88, 877-884 (2010).
23. Hattori Y, Kawakami S, Nakamura K, Yamashita F, Hashida M. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J. Pharmacol. Exp. Ther., 318, 828-834 (2006).
24. Ikemura M, Nishikawa M, Hyoudou K, Kobayashi Y, Yamashita F, Hashida M. Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice. Mol. Pharm., 7, 2069-2076 (2010).
25. Wu H, Xu JB, He YL, Peng JJ, Zhang XH, Chen CQ, Li W, Cai SR. Tumor-associated macrophages promote angiogenesis and lymph angiogenesis of gastric cancer. J. Surg. Oncol., 106, 462-468 (2012).
26. Kang JC, Chen JS, Lee CH, Chang JJ, Shieh YS. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J. Surg. Oncol., 102, 242-248 (2010).
27. Massi D, Marconi C, Franchi A, Bianchini F, Paglierani M, Ketabchi S, Miracco C, Santucci M, Calorini L. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: Evidence from human and experimental tumors. Hum. Pathol., 38, 1516-1525 (2007).
28. Sharda DR, Yu S, Ray M, Squadrito ML, De Palma M, Wynn TA, Morris SM Jr, Hankey PA. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J. Immunol., 187, 2181-2192 (2011).
29. Dangaj D, Abbott KL, Mookerjee A, Zhao A, Kirby PS, Sandaltzopoulos R, Powell DJ Jr, Lamazière A, Siegel DL, Wolf C, Scholler N. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PLoS ONE, 6, e28386 (2011).
30. Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res., 66, 11432-11440 (2006).
31. Swallow CJ, Murray MP, Guillem JG. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin. Exp. Metastasis, 14, 3-11 (1996).
32. Hagemann T, Robinson SC, Schulz M, Trümper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α-dependent upregulation of matrix metalloproteases. Carcinogenesis, 25, 1543- 1549 (2004).
33. Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Plüddemann A, Charles K, Gordon S, Balkwill FR. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol., 176, 5023-5032 (2006).
34. Sica A, Saccani A, Bottazzi B, Polentarutti N, Vecchi A, van Damme J, Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumorassociated macrophages. J. Immunol., 164, 762-767 (2000).
35. Watkins SK, Egilmez NK, Suttles J, Stout RD. IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol., 178, 1357-1362 (2007).
36. Kole R, Krainer AR, Altman S. RNA therapeutics: Beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov., 11, 125-140 (2012).
37. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, Sica A. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor-κB. Proc. Natl. Acad. Sci. U.S.A., 106, 14978-14983 (2009).